What's in Hadir F. El-Dessouky's pipeline?

Hadir F. El-Dessouky has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Hadir F. El-Dessouky's portfolio?

Top competitors by shared drug class: Indus Hospital and Health Network, Third Military Medical University, University of Rochester.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/hadir-f-el-dessouky.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Hadir F. El-Dessouky — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hadir F. El-Dessouky pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Polyunsaturated Fatty Acids	Polyunsaturated Fatty Acids	marketed	Dietary supplement / Nutraceutical		Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Indus Hospital and Health Network · 1 shared drug class
Third Military Medical University · 1 shared drug class
University of Rochester · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Hadir F. El-Dessouky:

Cite this brief

Drug Landscape (2026). Hadir F. El-Dessouky — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/hadir-f-el-dessouky. Accessed 2026-05-18.